Tech Company Financing Transactions
Panacea Pharmaceuticals Funding Round
On 7/8/2005, Panacea Pharmaceuticals raised $7 million in Series C funding from Mitsubishi Corporation.
Transaction Overview
Company Name
Announced On
7/8/2005
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series C
Investors
Proceeds Purpose
This is the third round of funding for Gaithersburg-based Panacea, a developer of drugs and diagnostics for cancer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
209 Perry Pkwy. 13
Gaithersburg, MD 20877
USA
Gaithersburg, MD 20877
USA
Phone
Website
Email Address
Overview
Panacea's mission is to seek, discover, develop, and market innovative products to treat diseases of the central nervous system and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hossein Ghanbari
Browse more venture capital transactions:
Prev: 7/7/2005: NextHop Technologies venture capital transaction
Next: 7/8/2005: ServiceSource venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs